积极探究, 奖学金, 咨询, and training in the science of mental health and illness to add to the fund of knowledge on which both theory and practice are based.
精神病学研究
The department of 精神病学 has continued to attract high profile researchers with NIH grants including ADHD authority Stephen Faraone and Empire Scholars Wei Dong Yao and Chunyu Liu. 研究 interests range from groundbreaking findings by Ma-li Wong and Julio Licinio linking schizophrenia to gut microbiomes, to research by Yingxi Lin that bridges the gap between molecular, cellular and systems neuroscience.
The department is further fueled by Stephen Glatt's research on genetic risk and resilience factors for a wide variety of disorders, including schizophrenia and Alzheimer’s disease, Usha Satish’s worldwide use of man-machine simulation methodologies to assess and train human factors and productivity across many fields and, Paula Trief’s international reputation for her work with persons with type 1 and type 2 diabetes.
Cutting edge methods including machine learning and bioinformatics have also emerged as novel techniques to facilitate exciting findings in psychiatric research. Through their NIH-funded and non-federal grants, as well as their collaborations with existing faculty, the Department of 精神病学 has soared from little funding to over $80,000,000 in cumulative grant funding since 2000. But more significant than research dollars are the department's long-range contributions to the field of psychiatry.
As the community's need for mental health services grows, so does the need for psychiatric research. 在回应, psychiatry research continues to grow exponentially at SUNY 推荐最近最火的赌博软件: Our clinical researchers are also making research gains in the fields of psychiatric genetics, 精神药理学, 预防自杀, 成瘾治疗, veteran mental health and work culture.
斯蒂芬·V. Faraone博士
Distinguished Professor and Vice Chair for 研究
Department of 精神病学, 纽约州立大学推荐最近最火的赌博软件医科大学
电子邮件: (电子邮件保护)
Through research, we create new knowledge. We figure out how to make better use of our resources and we develop more-targeted, 更高效的, more-effective treatments world-wide for psychiatric disorders and mental illness.
